Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: SciBase Holding AB

Market Cap 519M 54.44M 47.24M 43.55M 40.8M 76.23M 5.21B 77.82M 201M 2.51B 204M 200M 8.74B P/E Ratio 2026 *
-
P/E Ratio 2027 * -
Enterprise Value 519M 54.44M 47.24M 43.55M 40.8M 76.23M 5.21B 77.82M 201M 2.51B 204M 200M 8.74B EV / Sales 2026 *
7.88x
EV / Sales 2027 * 4.99x
Free-Float
77.17%
Yield 2026 *
-
Yield 2027 * -
1 day+1.60%
1 week+17.70%
Current month+9.48%
1 month+12.14%
3 months+81.43%
6 months+38.42%
Current year+47.25%
1 week 42.52
Extreme 42.52
54
1 month 37.5
Extreme 37.5
54
Current year 18.5
Extreme 18.5
54
1 year 18.5
Extreme 18.5
54
3 years 18.5
Extreme 18.5
148.4
5 years 18.5
Extreme 18.5
657
10 years 18.5
Extreme 18.5
3,020
Manager TitleAgeSince
Chief Executive Officer 59 01/10/2023
Director of Finance/CFO 64 01/01/2014
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 60 16/05/2017
Chairman 65 13/06/2024
Director/Board Member 68 -
Change 5-day change 1-year change 3-year change Capi.($)
+1.60%+17.70%+33.68%-59.29% 54.44M
+0.13%-2.49%+11.01%-31.57% 16.47B
+6.03%-2.53%+28.65%+60.84% 1.67B
-0.23%-0.84%-31.21%+17.70% 1.11B
+1.60%-0.31%-52.19%-83.03% 961M
-1.20%-4.29%-24.95%-55.23% 635M
-0.07%-2.76%-47.53%-59.63% 561M
+4.71%+13.33%+34.06%-50.07% 465M
-1.18%-4.41%-54.91%-62.43% 391M
+4.62%-8.55%+47.79% - 337M
Average +1.47%-0.28%-5.56%-35.86% 2.26B
Weighted average by Cap. +0.22%-5.87%+5.03%-26.81%

Financials

2026 *2027 *
Net sales 65.9M 6.91M 5.99M 5.52M 5.18M 9.67M 661M 9.87M 25.51M 319M 25.93M 25.37M 1.11B 104M 10.92M 9.48M 8.74M 8.18M 15.29M 1.05B 15.61M 40.34M 504M 40.99M 40.11M 1.75B
Net income -66.3M -6.95M -6.03M -5.56M -5.21M -9.73M -665M -9.93M -25.67M -321M -26.08M -25.52M -1.12B -51.5M -5.4M -4.68M -4.32M -4.05M -7.56M -517M -7.72M -19.94M -249M -20.26M -19.82M -866M
Net Debt - -
Logo SciBase Holding AB
SciBase Holding AB (publ) is a Sweden-based company engaged in the medical equipment industry. The Company specializes in the manufacture of point of care device, called Nevisense, which is aimed to detect of malignant melanoma. Nevisense analyze suspicious lesions by using Electrical Impedance Spectroscopy (EIS) which is applied as an electrical signal to the skin. SciBase Holding AB (publ) specializes in early detection and prevention in dermatology. The Company develops and commercializes Nevisense, a point-of-care platform that combines AI (artificial intelligence) and advanced EIS technology to elevate diagnostic accuracy, ensuring proactive skin health management. SciBase Holding AB (publ) combines advanced EIS technology with AI to empower healthcare professionals by improving diagnostic precision, facilitating disease monitoring, and enabling early detection of skin cancer.
Employees
49
Date Price Change Volume
11/06/26 50.80 kr +1.60% 2,799
10/06/26 50.00 kr +1.63% 8,492
09/06/26 49.20 kr +0.41% 30,687
08/06/26 49.00 kr +12.39% 18,849
05/06/26 43.60 kr +1.02% 2,457

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SCIB Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!